KIMBERLY POWELL: Open Payments
NPI 1861138901 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 21 payments from 11 companies in 2025. Trend: 2023 $797 · 2024 $588 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 3 | $62 |
| CSL Behring | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 3 | $44 |
| Grifols USA, LLC | 2 | $41 |
| GENZYME CORPORATION | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Electromed, Inc. | 3 | $31 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| 3B Medical, Inc. | 1 | $22 |
Products named: DUPIXENT, Tyvaso, Kcentra, Prolastin-C Liquid, INSPIRE, SMARTVEST, OPSYNVI, LUNA.
Industry payments across AR — which companies pay providers there.
